---
title: "Teasing out antipsychotic medication effects on DNA methylation"
subtitle: "Martens goes 2 Myrkdalen! <br/> &#x1F3D4; &#x1F6A1; &#x26F7;"  
author: 
  - "Jonelle"
date: "March 28-29, 2022"
output:
  xaringan::moon_reader:
    css: [xaringan-themer.css, yellow_dots.css, extra.css]
    nature:
      slideNumberFormat: "%current%"
      highlightStyle: github
      highlightLines: true
      ratio: 16:9
      countIncrementalSlides: true
---

```{r setup, include=FALSE}
options(htmltools.dir.version = FALSE)
knitr::opts_chunk$set(
  fig.width=9, fig.height=3.5, fig.retina=3,
  out.width = "100%",
  cache = FALSE,
  echo = TRUE,
  message = FALSE, 
  warning = FALSE,
  hiline = TRUE
)
library(fontawesome)
library(tidyverse)
library(xaringan)
library(xaringanExtra)
library(here)
```

```{r xaringan-themer, include=FALSE, warning=FALSE}
library(xaringanthemer)

dark_yellow <- "#EFBE43"
light_yellow <- "#FDF7E9"
gray <- "#333333"
blue <- "#4466B0"

black <- "#1381B0"
orange <- "#FF961C"
white <- "#FFFFFF"

style_duo(
  primary_color = light_yellow,
  secondary_color = dark_yellow,
  inverse_header_color = white,
  header_color = gray,
  text_color = gray,
  code_inline_color = colorspace::lighten(gray),
  text_bold_color = colorspace::lighten(gray),
  link_color = blue,
  title_slide_text_color = blue,
  
  # fonts
  header_font_google = google_font("Martel", "300", "400"),
  text_font_google = google_font("Lato"),
  code_font_google = google_font("Fira Mono") 
  
)
```


```{r xaringanExtra, echo=FALSE, warning=FALSE}

library(xaringanExtra)
xaringanExtra::use_logo("slides/UiBlogoMED_gray_v_Eng.png",
                        width = "250px",
                        height = "250px",
                        position = xaringanExtra::css_position(top = "2em", right = "2em"))
                     

xaringanExtra::use_tile_view()

```


```{css extra.css, echo=FALSE}

.small { 
  font-size: 0.75em
}  

.bitty { 
    font-size: 1.25em;
}

.enlarge { 
    font-size: 1.5em;
}

.fade {
  opacity: 0.66;
}

```

---

background-image: url(slides/Smigielski.png)
background-position:cover
background-size: 750px

.footnote[Smigielski _et al_, Molecular Psychiatry, 2020]


## **Epigenetics**


---

## Background 
   - AP drugs
   - Psychosis
   

---
## AP are the first line of treatment 
   - Treatment effects
   - Side effects

---
## Factors that influence the efficieny of AP
   - Age, gender, smoking <br> <br />
   - Genotype - i.e. metabolic enzymes <br> <br />
   - Polypharmacy <br> <br />
   - Time of day of administration <br> <br />
   
---
## The factors that influence the efficiency of AP also influence DNA methylation levels seen in peripheral blood.

Hypothesis: We hypothisize that differential DNA methylation associated with 
AP drugs identified in the peripheral blood of individuals taking these drugs, independent of diagnosis 

## need a caroon here 

---
class: top left 
###**GWAS findings relevant for AP project** [1] <br> <br />

.footnote[[1] SCZ Working Group of PGC, 2014]
.col-left[.enlarge[
 
*      ***GRIA1***, ***GRIN2A*** : glutamate <br> <br />
*     ***xxx*** : GABA <br> <br />
*      ***D2R*** : dopamine D2 receptor<br> <br />
*      ***CACNA1C*** : calcium voltage-gated channel <br> <br />
*       ***SLC39A8*** : Mn transporter
]
]



---
class: top left 
###**EWAS findings relevant for AP project** [1] <br> <br />

.footnote[[1] SCZ Working Group of PGC, 2014]
.col-left[.enlarge[

*     Candidate genes <br> <br />
*      Genome-wide <br> <br />
      
  ]
  ]

.footnote[[1]xxx]

---
## TOP Cohort

.enlarge[Challenges when teasing out medication effects on DNAm. <br> <br />
   - Polypharmacy <br> <br />
   - Small sample size <br> <br />
   - Missing values &#x1F641; <br> <br />
   - Model design ]
   
---
## Study/model design 

.enlarge[
Approaches to consider: <br>

   - Evaluate serum values (van Dongen) <br> <br />
   - Evaluate samples as one phenotype without correction for eCells (Greally & Lappalainen)
   ]

add photos of article titles

---
class:top left
### Cell-type populations are influenced by:

   - AP and polypharmacy <br> <br />
   - Gender, age, smoking, diet <br> <br />
   - Diagnosis & health status <br> <br />
   - Time of day & season <br> <br />

---

class:top left

### Models selected for Quetiapine n=92 <br> <br> <br/>

.enlarge[Mod1: DNAm ~ Serum1 + Serum2 + Serum_Lithium + Age + Sex + SmokingScore] <br> <br />

.enlarge[Mod2: DNAm ~ Serum1 + Serum2 + Serum_Lithium + Age + Sex + SmokingScore + <br> <br /> Mono + Neu + NK + CD4T + CD8T + Bcells]

---

class:top left
### Results for CpGs at Genome-wide significance

   - GLT8D1: Glycosyltransferase 8 Domain Containing 1 <br> <br />
   - SPCS1: signal peptidase complex subunit 1 <br> <br />
   - LOC100507065:long noncoding RNA <br> <br />

Limitation - Some samples with polypharmacy that need to be teased out. 

---
class: top left
### Manhatten plots comparing the two models 


.pull-left[Model 1: Adjustment for eCells: p-val=

![](slides/Que_n92_Mod1_manhatt.png)

]

.pull-right[Model 2: No adjustment for eCells: p-val=

![](slides/Que_n92_Mod2_manhatt.png)

]


---
### Glycosylation and glycan biosynthesis

Glycosyltansferases assemble monosaccharides into linear and branched sugar chain. 
The acceptor can be other mono- or oligosaccharides, lipids, or protein residues.

---
background-image: url(slides/Mealer_glyco.jpg)
background-position: 20% 75%
background-size: 350px

class: left top 

### GLT8D1 in psychiatry 

.pull-left[
*
*
*
*


]



---

.pull.left[.footnote[Williams, _et al.,_ Mol. Psychiatry, 2020]]
.pull-right[.footnote[Mealer, _et al.,_ Mol. Psychiatry 2020]]

---
class:top left
### GLT8D1 <br> -  transcripts associated with SCZ and BPD



.pull.left[.footnote[Ripke, _et al.,_ Nature Genetics, 2013]]
.pull-right[.footnote[Stahl EA, _et al.,_ Nature Genetics, 2019]]

---
class:top left
### GLT8D1 <br> - transcripts associated with SCZ 



.pull.left[.footnote[van der Meer, _et al.,_ Nature Communications, 2020]]



---
class:top left
### Differentially Methylated Regions (DMRs) <br/> 

.enlarge[- Statistically significant methylation status]

![](slides/DMRs_Que_n84.png) <br> <br />

.enlarge[For lipid lovers! APOB: Apolipoprotein B - ligand for LDL receptor]

---
class:top left
### Future prospects

### Quetiapine with poypharmacy to gain larger sample size
### Surrogate variable analysis

---
class:top left

## Continue work with a focus on

  - Aripiprazole (n=)
  - Olanzapine   (n=)
  - Quetiapine  (n=)  
  - Risperdal   (n=)



---
class:top left
background-image: url(slides/Myrkdalen.jpeg)
background-position: 25% 25%
background-size: 10px


# Acknowledgements <br>
.pull-right[
**Supervisor St√©phanie**<br><br>
**Co-Supervisor Anne-Kristin**<br><br>
**Colleagues in The Martens Group**<br><br>
**Dept. of Clinical Science II** <br><br><br>
**NORMENT** <br><br>
## &#x1F618; 

]


---

### And a nested list:

- level 1 item
  - level 2 item
  - level 2 item
    - level 3 item
    - level 3 item
- level 1 item
  - level 2 item
  - level 2 item
  - level 2 item
- level 1 item
  - level 2 item
  - level 2 item
- level 1 item

---

layout: false

## Square image

<center><img src="https://octodex.github.com/images/labtocat.png" alt="GithHub Octocat" height="400px" /></center>

.footnote[GitHub Octocat]

---



